Personalis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.

About PSNL

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives.

CEO

Christopher M. Hall

CEOChristopher M. Hall

Employees

229

Employees229

Headquarters

Fremont, California

HeadquartersFremont, California

Founded

2011

Founded2011

Employees

229

Employees229

PSNL Key Statistics

Market cap

809.18M

Market cap809.18M

Price-Earnings ratio

-7.18

Price-Earnings ratio-7.18

Dividend yield

—

Dividend yield—

Average volume

1.38M

Average volume1.38M

High today

$10.30

High today$10.30

Low today

$8.65

Low today$8.65

Open price

$9.93

Open price$9.93

Volume

2.05M

Volume2.05M

52 Week high

$10.35

52 Week high$10.35

52 Week low

$2.83

52 Week low$2.83

PSNL News

Nasdaq 3d

Personalis Moves 20.5% Higher: Will This Strength Last?

Personalis PSNL shares ended the last trading session 20.5% higher at $10.28. The jump came on an impressive volume with a higher-than-average number of shares...

TipRanks 4d

Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial

Personalis (PSNL) announced new data from an AstraZeneca (AZN) Phase 3 clinical trial in lung cancer, LAURA, demonstrating that Personalis’ NeXT Personal molecu...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own PSNL. This list is generated using Robinhood data, and it’s not a recommendation.